pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE AND ACETIC ACID (HYDROCORTISONE AND ACETIC ACID)
TARO
0 catalysts
HYDROXYZINE PAMOATE
HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)
IMPAX LABS INC
0 catalysts
HYMPAVZI
HYMPAVZI (MARSTACIMAB-HNCQ)
1 INDICATIONS AND USAGE HYMPAVZI is indicated for routine prophylaxis to prev…
Tissue factor pathway inhibitor
$PFEPFIZER INC
0 catalysts
HYRNUO
HYRNUO (SEVABERTINIB)
Bayer HealthCare Pharmaceuticals Inc
← prev
page 105 of 271
next →
131
Pain89
Neurology1
0 catalysts
Marketed
Haegarda
Haegarda (C1 esterase inhibitor (human))
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
CSL Behring LLC
0 catalysts
Preclinical
Half-Life Extended BiTE
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$AMGNAMGEN INC
0 catalysts
Phase 1
HbF Activating CELMoD
Sickle Cell Disease
Bristol-Myers Squibb Co
0 catalysts
Phase 2
HeXell-2020
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hexun Bioscience Co Ltd
0 catalysts
Phase 1
Hemay-181
Colon Cancer
Ganzhou Hemei Pharmaceutical Co Ltd
0 catalysts
Preclinical
Hemophilia A
Hemophilia A (Factor VIII Deficiency)
Sernova Biotherapeutics Inc
0 catalysts
Marketed
Heparin Sodium Fresenius
Heparin Sodium (heparin sodium)
Blood Coagulation
Fresenius Kabi USA LLC
0 catalysts
Marketed
Heteruam
Abacavir Sulfate + Lamivudine ((abacavir sulfate + lamivudine))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Hetero USA Inc
0 catalysts
Marketed
Hetlioz LQ
Hetlioz LQ (tasimelteon)
Circadian Rhythm Sleep Disorders
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Preclinical
Human Decorin Fused to the Truncated Homing Peptide CRK
Epidermolysis Bullosa
Theravia SAS
0 catalysts
Marketed
Hydromorphone Hydrochloride Hikma
Hydromorphone Hydrochloride (hydromorphone hydrochloride)
Pain
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
Hydromorphone Hydrochloride Pfizer
Hydromorphone Hydrochloride (hydromorphone hydrochloride)
Pain
$PFEPFIZER INC
0 catalysts
pre_registration
Hypertriglyceridemia
Hypertriglyceridemia
Apolipoprotein C-III mRNA 3'UTR
LP Pharmaceutical (Xiamen) Co Ltd
0 catalysts
Phase 1
IA-14069
Rheumatoid Arthritis
iLab Co Ltd
0 catalysts
Phase 2
IAE-0972
Cutaneous Squamous Cell Carcinoma (cSCC)
Sunho (China) Biopharmaceutical Co Ltd
0 catalysts
Phase 1
IAM-1363
Bladder Cancer
Iambic Therapeutics Inc
0 catalysts
Phase 2
IAP-0971
Cervical Cancer
Sunho (China) Biopharmaceutical Co Ltd
0 catalysts
Phase 2
IBB-0979
Solid Tumor
Sunho (China) Biopharmaceutical Co Ltd
0 catalysts
Phase 1
IBI-3020
Colon Cancer
Innovent Biologics Inc
0 catalysts
Phase 1
IBI-3032
Obesity
Innovent Biologics Inc
0 catalysts
Phase 2
IBI-363
Metastatic Melanoma
Innovent Biologics Inc
0 catalysts
Preclinical
IBIO-101
Solid Tumor
$IBIOiBio, Inc.
0 catalysts
Preclinical
IBP-1118
arginyl-glutamine
Retinopathy Of Prematurity
Infant Bacterial Therapeutics AB
0 catalysts
Phase 3
IBP-9414
Necrotizing Enterocolitis
Infant Bacterial Therapeutics AB
0 catalysts
Phase 1
IBRX-042
Head And Neck Cancer
$IBRXImmunityBio, Inc.
0 catalysts
Preclinical
IBUPROFEN
IBUPROFEN (IBUPROFEN)
Pain
Avecho Biotechnology Ltd
0 catalysts